15 07, 2024

Goldman Sachs’ Earnings Beat Fueled By Uptick in Fixed Income Trading: 3 Other Reasons to Buy GS

By |2024-07-15T17:30:31+00:00July 15th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , , |

Goldman Sachs (GS) reported its second-quarter earnings Monday morning, sending shares higher on the heels of earnings and revenue beats.  The company benefited from an increase to fixed income trading along with lower loan loss provisions than originally anticipated. Here are the Q2 results along with the analyst estimates: Earnings: $8.62/share vs $8.34/share expected. [...]

12 07, 2024

Nvidia Falls on Tough Trading Day Thursday, But We Still See 3 Reasons to BUY NVDA

By |2024-07-12T16:35:18+00:00July 12th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , , , , , |

Shares of Nvidia (NVDA) fell as much as 5.6% Thursday after a strong rally sent it on its way to setting a new record high. The stock had climbed more than 6% before all those gains washed away yesterday. The fall-off could be attributed to the latest inflation figures weighing the stock down - [...]

9 07, 2024

Intel Climbs as Analyst Upgrades the Stock on AI Growth: 2 Reasons We Think INTC is a BUY Today

By |2024-07-11T14:13:25+00:00July 9th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

Intel (INTC) gained more than 10% over the past week thanks to bullish coverage by one analyst at Melius Research who sees the stock as a top contender in the AI battlefield for the remainder of 2024. Ben Reitzes is optimistic about Microsoft’s new Recall AI and what it could mean for Intel, particularly [...]

8 07, 2024

Morgan Stanley Upgrades TSM Ahead of Earnings: 3 Reasons to Buy This Stock Today

By |2024-07-08T16:31:44+00:00July 8th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Taiwan Semiconductor Manufacturing Company (TSM) got a 3% boost Monday morning after analysts with Morgan Stanley were the latest to upgrade the stock.  The company is set to release its earnings on July 18th, and more and more experts are paying attention to the stock as the date approaches - you should [...]

2 07, 2024

Volkswagen is Investing Billions into Rivian: Why You Should Invest in RIVN, Too

By |2024-07-02T17:30:57+00:00July 2nd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

All eyes are on Volkswagen and Rivian right now, as just last week the two automakers teamed up to create an EV-focused joint venture. Volkswagen will gain access to Rivian’s EV technology and a heap of Rivian stock (RIVN) in exchange for up to a $5 billion investment. Shares of RIVN are up 30% [...]

27 06, 2024

Micron Tech Tumbles 6% on Less Than Fantastic Forecast: 3 Reasons It’s STILL Time to Buy MU

By |2024-06-27T17:45:34+00:00June 27th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Micron Tech (MU) reported its fiscal Q3 earnings results alongside a forecast for the final quarter of the fiscal year, and shares slid 6% as investors were expecting more. Revenue came in at $6.81 billion for the quarter, which was a whopping 81% improvement year over year. Analysts were expecting $6.61 billion.  Meanwhile, earnings [...]

26 06, 2024

FedEx Cost Cuts and Upbeat Outlook Send Shares 14% Higher: 3 Other Reasons to BUY FDX

By |2024-06-26T18:15:27+00:00June 26th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

It had been a tough past few months for FedEX (FDX) investors, who watched their positions plummet 14%. But shares have recovered all that and more today after the delivery company released positive 4th quarter results for fiscal 2024. Earnings came in at $5.94 per share, which was ahead of the analyst expectation of [...]

21 06, 2024

Sarepta Shoots up 36% on New Drug Breakthrough for DMD: 2 Reasons to Consider Buying SRPT

By |2024-06-21T17:20:17+00:00June 21st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , |

Sarepta Therapeutics (SRPT) announced late Thursday it had gained FDA approval for its treatment designed to target a rare genetic disease known as Duchenne muscular dystrophy (DMD). This condition causes progressive weakness, predominantly in boys, and is caused by a lack of key protein dystrophin. It has no known cure at this time. The [...]

19 06, 2024

Dell Was Down After Disappointing Earnings, But the Road to Recovery is Underway: Time to Buy?

By |2024-06-19T17:32:29+00:00June 19th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Just last month Dell Technologies (DELL) reported first-quarter earnings that fell short of Wall Street’s expectations, taking the stock down from its all-time high of $179/share. It fell more than 30% in just a few days, eroding market cap and scaring investors out of their positions.  The issue was that despite AI growth fueling [...]

Go to Top